µ¼Ê¦ÐÕÃû£ºÍõÜç
ÐÔ±ð£º
ÈËÆøÖ¸Êý£º37
ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧ
ËùÊôԺϵ£º»ù´¡Ò½Ñ§Ôº
Ö°³Æ£º¸±½ÌÊÚ
µ¼Ê¦ÀàÐÍ£ºË¶µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º
Ñо¿ÁìÓò£º ¶àÄêÀ´ÖÂÁ¦ÓÚ°×޼«´¼¿¹Ëèĸϸ°ûÁö·Ö×Ó»úÖÆ·½ÃæµÄÑо¿
Ñо¿ÁìÓò£º ¶àÄêÀ´ÖÂÁ¦ÓÚ°×޼«´¼¿¹Ëèĸϸ°ûÁö·Ö×Ó»úÖÆ·½ÃæµÄÑо¿ [ÊÕÆð]
ͨѶ·½Ê½ :
°ì¹«µç»°£º**
µç×ÓÓʼþ£ºwangqiandl73@163.com
¸öÈ˼òÊö :
ÍõÜç,²©Ê¿£¬¸±½ÌÊÚ£¬Ë¶Ê¿Ñо¿Éúµ¼Ê¦¡£ÏÖÔÚ´óÁ¬Ò½¿Æ´óѧ»ù´¡Ò½Ñ§ÔºÏ¸°ûÉúÎï½ÌÑÐÊÒ¹¤×÷¡£³Ðµ£ÁËÁôѧÉú¡¢Ñо¿Éú¡¢ÆßÄêÖÆ¡¢±¾¿ÆµÈ¶à¸ö²ã´ÎµÄ¡¶Ï¸°ûÉúÎïѧ¡·ºÍ¡¶Ò½Ñ§ÒÅ´«Ñ§¡·µÈ¿Î³ÌµÄÀíÂÛ¼°ÊµÑé½Ìѧ¹¤×÷¡£Ôø»ñ»ù´¡Ò½Ñ§ÔºÇàÄê½Ìʦ½²¿Î´óÈüµÚ¶þÃû£¬Äê¶È×îÊÜ»¶ÓµÄÊڿνÌʦ£¬»ù´¡Ò½Ñ§ÔºÓÅÐã¹²²úµ³Ô±µÈÈÙÓþ³ÆºÅ¡£Ö÷±àºÍ²Î±àÁË¡¶Ò½Ñ§Ï¸°ûÉúÎïѧ¡·£¬¡¶Ï¸°ûÉúÎïѧ¼òÃ÷½Ì³Ì¡·µÈÊé¼®¡£Ö÷Òª´ÓÊÂÖ×Áö·Ö×ÓÉúÎïѧ·½ÃæµÄÑо¿¹¤×÷¡£¶àÄêÀ´ÖÂÁ¦ÓÚ°×޼«´¼¿¹Ëèĸϸ°ûÁö·Ö×Ó»úÖÆ·½ÃæµÄÑо¿¡£½Òʾ°×޼«´¼ÄÜÒÔFas·ÇÒÀÀµÐÔ;¾¶ÒÖÖÆËèĸϸ°ûÁöϸ°ûÉú³¤²¢ÓÕµ¼Æä·Ö»¯ºÍµòÍö¡£²ûÃ÷°×޼«´¼¿¹Ëèĸϸ°ûÁöµÄÐźÅÍøÂç×÷ÓÃÌØµã¡£Ö÷³ÖÊ¡½Ìίһ°ãÏîĿһÏ2008Ä꣩£¬ÁÉÄþÊ¡×ÔÈ»¿ÆÑ§»ù½ðÒ»Ï2013Ä꣩£¬¶þÏî¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîĿִÐиºÔðÈË£¬»ñµÃÊ¡×ÔÈ»¿ÆÑ§¶þµÈ½±Ò»ÏÖлªÒ½Ñ§»áÈýµÈ½±£¬·¢Ã÷רÀû2Ï½üÄêÀ´ÒÔµÚÒ»×÷Õß·¢±íSCIÂÛÎÄ3ƪ¡£
¿ÆÑй¤×÷ :
³Ðµ£µÄ¹ú¼Ò¼¶ÏîÄ¿£º£¨½ü5Ä꣩
1.¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ »ùÓÚÁ½ÖÖÔ·¢ÐÔÄÔÖ×ÁöµÄ°×޼«´¼´úÐ»ÌØµã¼°ÆäÓ뿹°©»îÐÔ¹ØÏµµÄÑо¿ 2011.1-2013.12 ÅÅÃû2
2.¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿°×޼«´¼¶ÔËèĸϸ°ûÁöÐźÅÍøÂçµÄµ÷½ÚÌØµã¼°Éñ¾Ö×ÁöѧÒâÒå2010.1-2012.12 ÅÅÃû2
3.¸ßµÈѧУ²©Ê¿Ñ§¿ÆµãרÏî¿ÆÑлù½ðÁªºÏ×ÊÖú¿ÎÌ⣨²©µ¼Àࣩ£¬2013.1-2015.12 ÅÅÃû4
4.ÁÉÄþÊ¡×ÔÈ»¿ÆÑ§»ù½ð °×޼«´¼¶ÔƤ·ôÁÛ×´ÉÏÆ¤°©WntºÍSHHÐźÅͨ·µÄÓ°Ïì¼°ÆäÁÙ´²Ö×ÁöѧÒâÒå·ÖÎö 2013.1-2015.12 Ö÷³Ö
´ú±íÐÔÂÛÎÄ£¨½ü5Ä꣩£º
[1] Zhi-Li Liu, Hong Li, Jia Liu, Mo-Li Wu, Xiao-Yan Chen,Li-Hong Liu , Qian Wang Inactivated Wnt Signaling in Resveratrol-suppressed Epidermal Squamous Cancer Cells and Its Biological Implication. Oncology Reports(accepted,ͨѶ×÷Õß)
[2] Fu Yuan-Shan, Wang Qian, Ma Jing-Xin, Yang Xiang-Hong, Wu Mo-Li, Zhang Kai-Li, Kong Qing-You, Chen Xiao-Yan, Sun Yuan, Chen Nan-Nan, Shu Xiao-Hong, Li Hong, Liu Jia. CRABP-II methylation: A critical determinant of retinoic acid resistance of medulloblastoma cells. Molecular Oncology£¨IF6.379£©. 6:48¨C61£¬2012.(¹²Í¬µÚÒ»×÷Õß).
[3] Shu Xiao-Hong, Li Hong, Sun Xiao-Xin, Wang Qian, Sun Zheng, Wu Mo-Li, Chen Xiao- Yan, Li Cong, Kong Qing-You, Liu Jia. Metabolic patterns and biotransformation activitiesof resveratrol in human glioblastoma cells: relevance with therapeutic efficacies. PLoS One(IF3.534). 6(11):e27484, 2011.
[4] Sun Yuan, Gao Xue, Liu Jia, Kong Qing-You, Chen Xiao-Yan, Wang Qian, Cheng Yi-Fan, Qu Xiao-Xia, Li Hong. Differential Notch1 and Notch2 expression and frequent activation of Notch signaling in gastric cancers. Arch Pathol Lab Med. (IF2.577)135:451-458, 2011.
[5] Wen Shu, Li Hong, Wu Mo-Li, Fan Shao-Hua, Wang Qian, Shu Xiao-Hong, Kong Qing-You, Chen Xiao-Yan and Liu Jia. Inhibition of NF-?B Signaling Commits Resveratrol- treated Medulloblastoma Cells to Apoptosis without Neuronal Differentiation J Neurooncol(IF5.025). 104:169¨C177, 2011.
[6] Shu Xiao-Hong, Li Hong, Sun Zheng, Wu Mo-Li, Ma Jing-Xin, Wang Jian-Min, Wang Qian, Sun Yuan, Fu Yuan-Shan, Chen Xiao-Yan, Kong Qing-You, Liu Jia. Identification of metabolic pattern and bioactive form of resveratrol in human medulloblastoma cells. Biochem Pharmacol.( IF4.650 )79:1516-25£¬2010.
½ÌÓý±³¾° :
2004Äê9Ô¡ª2008Äê6Ô Àíѧ²©Ê¿ ´óÁ¬Ò½¿Æ´óѧ£»1995Äê9Ô¡ª1998Äê7Ô Àíѧ˶ʿ ÁÉÄþʦ·¶´óѧ£»1991Äê9Ô¡ª1995Äê7Ô Àíѧѧʿ ÁÉÄþʦ·¶´óѧ¡£
´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÍõÜç
±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø/2019-05-27
Ïà¹Ø»°Ìâ/ϸ°û »ù´¡Ò½Ñ§Ôº ÅÅÃû ÐźŠϸ°ûÉúÎïѧ
2019ÖйúÈËÃñ´óѧÓïÑÔѧ¼°Ó¦ÓÃÓïÑÔѧ×ÜÅÅÃûµÚÒ»¾ÑéÌû
Ò»¡¢¸öÈËÇé¿ö ±¨¿¼Ñ§Ð£¼°öλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÖйúÈËÃñ´óѧ£¬ÓïÑÔѧ¼°Ó¦ÓÃÓïÑÔѧ ³õÊÔÅÅÃûµÚ1£¬×Ü·Ö397·Ö£¨ÕþÖÎ68£¬Ó¢ÓïÒ»78£¬ººÓïÑÔ»ù´¡115£¬ÓïÑÔѧ»ù´¡136£© ¸´ÊÔÅÅÃûµÚ2£¬×Ü·Ö290£¨Âú·Ö350£© ×ÛºÏÅÅÃûµÚ1£¬×ܳɼ¨80.78£¨Äâ¼ȡ£© ¶þ¡¢±¸¿¼¾Ñé ¡¾ÕþÖΡ¿ 1. öλÔÓéÀÖ¹Ù·½appÏÂÔØ£º £¨1£©Ð¤ÐãÈÙ£º¾«½²¾«Á·¡¢1000Ìâ¡¢½²ÕæÌ⡢Ф°Ë¡¢Ð¤ ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØ¾Ñé °×ÌÒÆßÆß öλÔÓéÀÖ¹Ù·½appÏÂÔØ¼ÓÓÍÕ¾ 2019-05-262020ÄêöλÔÓéÀÖ¹Ù·½appÏÂÔØ:½ðÈÚר˶ԺУÅÅÃûTOP100
¡¡¡¡½ðÈÚר˶ÊDZ¨¿¼ÈÈÃÅ£¬Á˽â½ðÈÚר˶ԺУÅÅÃûÇé¿ö£¬´ó¼Ò²ÅÄܸüºÃµØÔñУ¡£±¾ÎÄ·ÖÏí½ðÈÚר˶ԺУÅÅÃûTOP100£¬´ó¼Ò¿´¿´¡¡¡¡1 A++ ÖйúÈËÃñ´óѧ¡¡¡¡2 A++ ±±¾©´óѧ¡¡¡¡3 A++ ¸´µ©´óѧ¡¡¡¡4 A++ ÏÃÃÅ´óѧ¡¡¡¡5 A+ ÄÏ¿ª´óѧ¡¡¡¡6 A+ ÉϺ£²Æ¾´óѧ¡¡¡¡7 A+ Õã½´óѧ¡¡¡¡8 A ÄϾ©´óѧ¡¡¡¡9 A Î人´óѧ¡¡¡¡10 A ÖÐÄϲƾÕþ·¨´óѧ¡¡ ...öλÔÓéÀÖ¹Ù·½appÏÂÔØ±¨¿¼ÐÅÏ¢ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-26ÐźÅÓëϵͳ°Â±¾º£Ä·Ó¢Îİæ¿Îºó´ð°¸
ÐźÅÓëϵͳ°Â±¾º£Ä·Ó¢Îİæ¿Îºó´ð°¸chapter1.pdf 298.3 KB 2011-04-20 20:21 -a-- ÐźÅÓëϵͳ°Â±¾º£Ä·Ó¢Îİæ¿Îºó´ð°¸chapter3.pdf 563.4 KB 2011-04-20 20:21 -a-- ÐźÅÓëϵͳ°Â±¾º£Ä·Ó¢Îİæ¿Îºó´ð°¸chapter4.pdf 381.9 KB 2011-04-20 20:27 -a-- ÐźÅÓëϵͳ°Â±¾º£Ä·Ó¢Îİæ¿Îºó´ð°¸chapter5.p ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-04-14ÐźÅÓëÏßÐÔϵͳ·ÖÎöÈ˽̰æÎâ´óÕýµÚ4°æ´ð°¸Ï°ÌâÈ«½â
µÚÒ»Õ ÐźÅÓëϵͳ ƒÈÈÝÌáÒª ¨D¡¢Ðźŵ͍ÒåÓë·ÖÀà 1. ¶¨Òå ÐźÅÊÇ´øÓÐÐÅÏ¢(ÈçÓïÑÔ¡¢ÒôÀÖ¡¢Í¼Ïñ¡¢Êý¾ÝµÈ)µÄËæÊ±¼ä(ºÍ¿Õ¼ä)±ä»¯µÄÎïÀíÁ¿»òÎï ÀíÏÖÏóÆäËæÊ±¼ä/±ä»¯µÄͼÏñ³ÆÎªÐźŵIJ¨ÐΡ£ 2. µäÐ͵ÄÁ¬ÐøÊ±¼äÐźűí´ïʽ¼°ÌØÐÔ (1£¾Ö¸ÊýÐźŠ/(/)= KeM ʽÖÐaÊÇʵÊý Ö¸ÊýÐźŵÄÒ»¸öÖØÒªÌØÐÔÊÇËü¶Ôʱ¼äµÄ΢·Ö ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-04-14Î÷°²µç×ӿƼ¼´óѧÐźÅÓëϵͳ¿Î¼þ
ÐźÅÓëϵͳ¿Î¼þ-Î÷°²µç×ӿƼ¼´óѧchapter1.pdf 968.4 KB 2010-09-25 14:44 -a-- ÐźÅÓëϵͳ¿Î¼þ-Î÷°²µç×ӿƼ¼´óѧchapter2.pdf 664.5 KB 2010-09-25 14:45 -a-- ÐźÅÓëϵͳ¿Î¼þ-Î÷°²µç×ӿƼ¼´óѧchapter3.pdf 928.1 KB 2010-09-25 14:46 -a-- ÐźÅÓëϵͳ¿Î¼þ-Î÷°²µç×ӿƼ¼´óѧchapter4.pdf ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-04-14Î÷°²µç×ӿƼ¼´óѧÐźÅÓëϵͳ¸¨µ¼°à±Ê¼Ç
.. ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-04-13Ìì½ò´óѧÐźÅÓëÏßÐÔϵͳ¸¨µ¼°à±Ê¼Ç
.. ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-04-12Ìì½ò´óѧÐźÅÓëϵͳ±¾¿Æ¿Î¼þ
1.ͨÐÅ¡¢µç×ÓºÍ²â¿ØÀàµÈöλÔÓéÀֵǼÈë¿ÚÏÂÔØ¼¼Êõ»ù´¡¿Î£¬ÊǺóÐø¿Î³Ì¡¶Í¨ÐÅÔÀí¡·¡¢¡¶×Ô¶¯¿ØÖÆ¡·¡¢¡¶Êý×ÖÐźŴ¦Àí¡·µÈµÄ»ù´¡ 2.Ñо¿ÉúÈëѧöλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÆÄ¿ 3.ÏÈÐ޿γ̣º¸ßµÈÊýѧ¡¢¹¤³ÌÊýѧ¡¢µç·»ù´¡µÈ(΢·Ö·½³Ì¡¢²î·Ö·½³Ì¡¢¼¶Êý£»Óëµç·µÄÇø±ð) [1]Îâ´óÕý¡¶ÐźÅÓëÏßÐÔϵͳ·ÖÎö¡·µÚ4°æ£¬¸ßµÈ½Ì Óý³ö°æÉ磬2005Äê¡£ [2]Ö£¾ýÀï¡¶ÐźŠ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-04-12Êý×ÖÐźŴ¦Àí½Ì³Ì¸´Ï°öλÔÓéÀÖ¹Ù·½appÏÂÔØ ÁõħÍõ¹¤×÷ÊÒ
.. ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-04-12Êý×ÖÐźŴ¦Àí¸´Ï° Ç廪´óѧ³ö°æÉç ³ÌÅåÇåµÚÈý°æ
µÚÒ»Õ£ºÀëɢʱ¼äÐźÅÓëϵͳ µÚ¶þÕ£ºZ±ä»» µÚÈýÕ£ºÀëÉ¢¸µÁ¢Ò¶±ä»» µÚËÄÕ£ºFFT µÚÎåÕ£ºÊý×ÖÂ˲¨Æ÷µÄ»ù±¾»ú¹¹ µÚÁùÕ£ºIIRÊý×ÖÂ˲¨Æ÷µÄÉè¼Æ·½·¨ µÚÆßÕ£ºFIRÊý×ÖÂ˲¨Æ÷µÄÉè¼Æ·½·¨ µÚ°ËÕ£ºÊý×ÖÐźŴ¦ÀíÖеÄÓÐÏÞ×Ö³¤Ð§Ó¦ 1£®ÐźŵķÖÀàÁ¬ÐøÊ±¼äÐźš¢Àëɢʱ¼äÐźš¢Êý×ÖÐźţ» Á´½Ó£ºhttps://pan.baidu.com/s/ ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-04-12ÉϺ£½»Í¨´óѧÉúÎïҽѧÊý×ÖÐźŴ¦Àí²¿·ÖϰÌâ½â´ð
.. ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-04-12Ç廪´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÐźÅÓëϵͳöλÔÓéÀÖ¹Ù·½appÏÂÔØÈȵã±Ê¼Ç
.. ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-04-10ÃŰ®¶«Êý×ÖÐźŴ¦Àí ±±Óʸ´ÊÔ±ØÓÃ
.. ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-04-10¶«±±´óѧ ͨÐÅÓëÐÅϢϵͳ ÐźÅÓëϵͳ¸¨µ¼°à±Ê¼Ç
Á´½Ó£ºhttps://pan.baidu.com/s/1r8v_LpCdg5Iz4_g_wB0tTQ ÌáÈ¡Â룺d786 ¸´ÖÆÕâ¶ÎÄÚÈݺó´ò¿ª°Ù¶ÈÍøÅÌÊÖ»úApp£¬²Ù×÷¸ü·½±ãŶ ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-04-09µç×ӿƼ¼´óѧÐźÅÓëϵͳ±Ê¼Ç
... ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-04-09
